Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 3 |
2021 | 3 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Amivantamab-Vmjw: A Novel Treatment for Patients with NSCLC Harboring EGFR Exon 20 Insertion Mutation after Progression on Platinum-Based Chemotherapy.
Biomedicines. 2023 Mar 20;11(3):950. doi: 10.3390/biomedicines11030950.
Biomedicines. 2023.
PMID: 36979929
Free PMC article.
Review.
Androgen receptor inhibitor treatments: Cardiovascular adverse events and comorbidity considerations in patients with non-metastatic prostate cancer.
Morgans AK, Shore N, Cope D, McNatty A, Moslehi J, Gomella L, Sartor O.
Morgans AK, et al. Among authors: mcnatty a.
Urol Oncol. 2021 Jan;39(1):52-62. doi: 10.1016/j.urolonc.2020.08.003. Epub 2020 Sep 18.
Urol Oncol. 2021.
PMID: 32958445
Free article.
Review.
Item in Clipboard
Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer.
Hussain A, Tripathi A, Pieczonka C, Cope D, McNatty A, Logothetis C, Guise T.
Hussain A, et al. Among authors: mcnatty a.
Prostate Cancer Prostatic Dis. 2021 Jun;24(2):290-300. doi: 10.1038/s41391-020-00296-y. Epub 2020 Oct 7.
Prostate Cancer Prostatic Dis. 2021.
PMID: 33028943
Free PMC article.
Review.
Item in Clipboard
Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer.
Velez MG, Kosiorek HE, Egan JB, McNatty AL, Riaz IB, Hwang SR, Stewart GA, Ho TH, Moore CN, Singh P, Sharpsten RK, Costello BA, Bryce AH.
Velez MG, et al. Among authors: mcnatty al.
Prostate Cancer Prostatic Dis. 2022 Sep;25(3):479-483. doi: 10.1038/s41391-021-00430-4. Epub 2021 Jul 22.
Prostate Cancer Prostatic Dis. 2022.
PMID: 34294873
Free PMC article.
Item in Clipboard
Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM Mutations.
Marshall CH, Sokolova AO, McNatty AL, Cheng HH, Eisenberger MA, Bryce AH, Schweizer MT, Antonarakis ES.
Marshall CH, et al. Among authors: mcnatty al.
Eur Urol. 2019 Oct;76(4):452-458. doi: 10.1016/j.eururo.2019.02.002. Epub 2019 Feb 21.
Eur Urol. 2019.
PMID: 30797618
Free PMC article.
Item in Clipboard
CDK12-Altered Prostate Cancer: Clinical Features and Therapeutic Outcomes to Standard Systemic Therapies, Poly (ADP-Ribose) Polymerase Inhibitors, and PD-1 Inhibitors.
Antonarakis ES, Isaacsson Velho P, Fu W, Wang H, Agarwal N, Sacristan Santos V, Maughan BL, Pili R, Adra N, Sternberg CN, Vlachostergios PJ, Tagawa ST, Bryce AH, McNatty AL, Reichert ZR, Dreicer R, Sartor O, Lotan TL, Hussain M.
Antonarakis ES, et al. Among authors: mcnatty al.
JCO Precis Oncol. 2020;4:370-381. doi: 10.1200/po.19.00399. Epub 2020 Apr 21.
JCO Precis Oncol. 2020.
PMID: 32462107
Free PMC article.
Item in Clipboard
Cite
Cite